Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)

نویسندگان

چکیده

Introduction Tricyclic antidepressants (TCAs) have an important role in pharmacotherapy of Major Depressive Disorder (MDD). TCA dosing is aimed at achieving a concentration the therapeutic window. Due to inter-individual differences activity Cytochrome P450 (CYP) 2D6 and 2C19, (enzymes involved metabolism) patients require individualized dose. Currently, finding suitable dosage process trial-and-error, including multiple drug measurements dose adjustments. A starting based on patient CYP2D6 CYP2C19 metabolizer phenotype may contribute more quickly, possibly resulting higher treatment efficacy occurrence fewer adverse effects. Objectives We study whether genotype-informed TCAs leads faster attainment plasma concentrations, reduction depression severity symptoms less Methods conducted double-blind randomized clinical trial, which (18-65 years) diagnosed with severe MDD eligible for were two arms: The intervention arm (Pharmacogenetics Informed Treatment; PIT) standard (Treatment As Usual; TAU). Patients treated nortriptyline, clomipramine or imipramine seven weeks depressive symptom effects monitored weekly. primary outcome measure, time needed attain concentration, was analyzed using Kaplan-Meier analyses. secondary measures, effects, mixed model linear regression. Results In total, we 111 patients. PIT group (n=56) reached significantly (Kaplan Meier, X2 (1) = 4.3, p=0.039) compared TAU (n=55), especially nortriptyline. On average decreased relatively than TAU, although this not different: F(6) 0.45, p 0.84. events during period differed between (F(6)=3.10, p=0.008). experienced last study. Conclusions Genotype-informed concentrations does lead Although able demonstrate that better response, conclude pharmacogenetics can optimization pharmacological treatment. Future research focus subgroups be great value, such as specific abnormal pharmacogenetic profile. Disclosure Interest None Declared

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes. Amitriptyline, clomipramine, doxepin, imipramine, and trimipramine are demethylated by CYP2C19 to pharmacologically active metabolites. These drugs and their metabolites, along with desipramine and nortriptyline, undergo hydroxy...

متن کامل

evaluation of pharmaceutical products of st. john’s wort efficacy added on tricyclic antidepressants in treating major depressive disorder: a double blind randomized control trial

background major depressive disorder (mdd) is the most common disorder in our community. hypericum perforatumm, is a herb with a long application history in treating depression. a controlled study to evaluate the effects of this herbal medicine in iran did not exist. objectives this study aimed to assess the effect of hypericum perforatom (perforan), in combination with tricyclic antidepressant...

متن کامل

Treatment of Major Depressive Disorder with Iyengar Yoga and Coherent Breathing: A Randomized Controlled Dosing Study

OBJECTIVES The aims of this study were to assess the effects of an intervention of Iyengar yoga and coherent breathing at five breaths per minute on depressive symptoms and to determine optimal intervention yoga dosing for future studies in individuals with major depressive disorder (MDD). METHODS Subjects were randomized to the high-dose group (HDG) or low-dose group (LDG) for a 12-week inte...

متن کامل

Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial

BACKGROUND Major depressive disorder (MDD) is the most common disorder in our community. Hypericum perforatumm, is a herb with a long application history in treating depression. A controlled study to evaluate the effects of this herbal medicine in Iran did not exist. OBJECTIVES This study aimed to assess the effect of Hypericum perforatom (perforan), in combination with tricyclic antidepressa...

متن کامل

The effect of ketamine versus thiopental sodium on hemodynamic profile and seizure duration during electroconvulsive therapy in patients with major depressive disorder: A randomized cross-over clinical trial

Background: Electroconvulsive therapy (ECT) is an effective treatment in major depressive disorder (MDD). Earlier studies suggest that ketamine has antidepressive effects and prolongs seizure duration in favor of therapeutic efficacy of ECT. A great concern with the use of ketamine is its possible adverse hemodynamic effects during ECT. This study was conducted to compare the hemodynamic effect...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Psychiatry

سال: 2023

ISSN: ['0924-9338', '1778-3585']

DOI: https://doi.org/10.1192/j.eurpsy.2023.275